Proteomics: Page 2

SomaLogic CEO steps down; Q4 revenue declines 18%

By Leo O'Connor

SomaLogic is at a stage where it needs "seasoned leaders to accelerate market adoption," said Troy Cox, executive chairman of the board of directors.

March 29, 2023

PreludeDx obtains CMS advanced approval for DCIS test

By LabPulse.com staff writers

The CMS approval, effective April 1, confirms that the test meets specific criteria established for laboratory tests under the Protecting Access to Medicare Act of 2014 (PAMA).

March 28, 2023

Quantum-Si launches next-generation single-molecule sequencing platform

By LabPulse.com staff writers

According to the firm, the small footprint and lower price of the new platform are aimed at providing greater accessibility to high-resolution sequencing data.

December 20, 2022

Quantum-Si study demonstrates semiconductor-based single-molecule protein sequencing

By LabPulse.com staff writers

The semiconductor chip contains millions of wells, enabling the cataloguing of many proteins in parallel and the understanding of how these proteins are modified at the single-molecule level.

October 14, 2022

NanoMosaic obtains rights to biomarker test for the diagnosis, prognosis of anesthesia-induced delirium, Alzheimer's

By LabPulse.com staff writers

The test uses the Tessie system to alleviate bottlenecks in proteomics analysis and to enable protein interrogation as well as multiomics analysis within a single chip during one run.

October 12, 2022

Multiomics firm Pleno closes $40 million Series A financing

By LabPulse.com staff writers

Pleno said its enabling technology leverages signal processing techniques from telecom to deliver ultra-high plexity, targeted biological information at high throughput.

October 12, 2022

OncoHost preparing launch of proteomics diagnostics platform for cancer, immunotherapy

By LabPulse.com staff writers

The appointments come ahead of the company's launch of its AI-powered diagnostic platform called PROphet.

October 3, 2022

U.K. study: Blood test may predict long-COVID risk

By Maryam Payne

A U.K. study led by researchers at University College London (UCL) shows that a blood test performed during the initial infection period may predict who is most likely to develop long COVID.

September 29, 2022

Thermo Fisher promotes new mass spectrometry instrument

By LabPulse.com staff writers

The instrument is called Orbitrap Ascend Tribrid, and it offers capability for multiplexed proteomics and native protein characterization, according to Thermo Fisher. It can analyze more samples at lower concentrations, and features an ion source for calibration the company calls Auto-Ready.

August 28, 2022

Philips adopting proteomics results for patient management

By LabPulse.com staff writers

The integration of proteomics results from the blood-based test -- along with the radiologic and patient history data currently used to determine treatment decisions -- can help create diagnostic efficiency for cancer care centers, Philips said.

June 29, 2022

Sera validates blood test in pregnant women at risk of bad outcomes

By LabPulse.com staff writers

The PreTRM test can predict the risk of preterm birth in asymptomatic, singleton pregnancies to help identify infants more likely to be born before 32 weeks of gestation as well as those more likely to experience an increased length of neonatal hospital stay and severe adverse neonatal outcomes, the company noted.

May 21, 2020

Quest reports supportive data for new HDL cholesterol function test

By LabPulse.com staff writers

The assay is a proteomic-based test of cholesterol efflux capacity (CEC), meaning the ability of HDL particles to accept cholesterol from white blood cells and begin the process of reverse cholesterol transport. The test assesses the function of apolipoproteins as a predictor of cholesterol efflux capacity, with results presented in a risk score. It was developed at Cleveland HeartLab, which was acquired by Quest in December 2017.

November 14, 2019

Previous Page

Page 2 of 2